VG – 0.3 – Shince Pharmaceuticals

VG – 0.3

Customer Review 0

★★★★★ 5/5

INDICATION & USE

• Improvement of postprandial hyperglycemia

• Diabetes mellitus when sufficient effect has not been obtained

Share it :

Description
Reviews (0)

Description

Voglibose Tablets

Composition:

Each uncoated tablet contains :

Voglibose IP 0.3 mg

INDICATION & USE

• Improvement of postprandial hyperglycemia

• Diabetes mellitus when sufficient effect has not been obtained

Reviews

There are no reviews yet.

Be the first to review “VG – 0.3”

CARFOSIN
Enquire Now
CALLOSIN- PLUS
Enquire Now
RESILAC
Enquire Now
ARORINX
Enquire Now

Signup our newsletter to get update information, news, insight or promotions.

Shince Pharmaceuticals Pvt Ltd., a division of Surien Pharmaceuticals (P) Ltd., delivers excellence in pharmaceutical manufacturing and innovation worldwide.

VG – 0.3

INDICATION & USE

Description

Voglibose Tablets

Composition:

INDICATION & USE

Reviews

CARFOSIN

CALLOSIN- PLUS

RESILAC

ARORINX

Signup our newsletter to get update information, news, insight or promotions.

Get in touch

Useful Links

Product Categories